Conducting clinical trials during the COVID-19 pandemic
Conducting clinical trials during the COVID-19 pandemic
复制标题
DOI：
10.1080/09546634.2020.1759770
复制
发表时间：
2020-05-18
影响因子：
2.9
通讯作者：
Shi, Vivian Y.
中科院分区：
文献类型：
--
作者：
Collier, Erin K.;Hsiao, Jennifer L.;Shi, Vivian Y.
由于强制政府和机构关闭以及新实施的限制，新冠肺炎大流行极大地影响了皮肤科临床试验操作。在这一史无前例的时期，应采取措施维持研究行为的合规性，同时确保试验工作人员和参与者的安全。在此，我们强调了新冠肺炎大流行期间皮肤科试验面临的挑战，并提供了保持合规和安全进行的策略。
The COVID-19 pandemic has greatly impacted dermatology clinical trial operations due to mandated governmental and institutional shut-downs and newly implemented restrictions. During this unprecedented time, measures should be taken to maintain research conduct compliance while also ensuring the safety of trial staff and participants. Herein, we underscore the challenges facing dermatology trials during the COVID-19 pandemic, and offer strategies to maintain compliant and safe conduct.